Cialis (tadalafil) 2.5 mg — Point32Health

Initial criteria

• Diagnosis of Benign Prostatic Hyperplasia (BPH)
• Requested dosage of tadalafil (Cialis) does not exceed FDA-approved recommended dose of up to 5 mg per day for the treatment of Benign Prostatic Hyperplasia (BPH)
• Documented trial and failure with adverse reaction to, or contraindication to a trial of at least two medications from either of the following drug classes: Alpha-1 Adrenergic Blockers (e.g., alfuzosin, doxazosin, tamsulosin, terazosin) OR 5-Alpha Reductase Inhibitors (e.g., finasteride, Avodart)

Approval duration

12 months